Abstract
Plasma level of androgens were studied in 47 normal male controls (20–50 yr-old; mean age 38 yr) and in a group of forty-one male diabetics (23–55 yr-old; mean age: 37.5 yr). Of these 36 showed type 11 and 5 type I diabetes. The results showed that while the mean basal plasma LH was unchanged, there was a decrease in testosterone levels in the diabetics. Moreover, testosterone binding globulin (TeBG) capacity appeared to be augmented and, as a consequence, the apparent free testosterone concentration (AFTC) was markedly decreased. It is interesting to note that the anomalies in androgen secretion observed are rather similar to those found in elderly man and could play some role (with other factors) in the onset of the frequent sexual disturbances in male diabetics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schöffling K., Federlin K., Ditschuneit H., Pfeiffer E.F. Disorders of sexual function in male diabetics. Diabetes 72: 519, 1963.
Bataille J.P. La fonction testiculaire du diabetique impuissant. Elimination urinaire des 17-cétostèroides et des gonadotrophines. Ann. Endocrinol. (Paris) 20: 750, 1963.
Faerman I., Vilar O., Rivarola M., Rosner J., Jadziusky M., Fox D., Perez-Lloret A., Bemsteinhahn L, Saraceni D. Impotence and diabetes. Studies of androgenic function in diabetic impotent males. Diabetes 21: 23, 1972.
Miller S., Mason H.L. Excretion of 17-ketosteroids by diabetics. J. Clin. Endocrinol. Metab. 5: 220, 1945.
Ellemberg M. Impotence in diabetes: the neurological factor. Ann. Intern. Med. 75: 213, 1977.
Franchimont P., Burger H. Gonadotrophins and testicular disorders. In: Franchimont P., Burger H. (Eds.), Human growth and gonadotrophins in health and disease. North Holland-American Elsevier, 1975, p. 323.
Kolodny R.C., Kahan C.B., Goldstein H.H., Barnett D.H. Sexual disfunction in diabetic men. Diabetes 23: 306, 1974.
Vermeulen A. Testosterone in plasma, a physiopathological study. Verhandelingen van den Koninklijke Academic voor Geneeskunde van Belgie. XXXV, 2: 95, 1973.
Distiller L.A., Morley J.E., Joffe B.L., Seftel H.G. Pituitary responsiveness to Luteinizing Hormone-releasing Hormone in insulin dependent Diabetes Mellitus. Diabetes 24: 378, 1975.
Rubens R., Dhont M., Vermeulen A. Further studies on Leydig cell function in old age. J. Clin. Endocrinol. Metab. 39: 40, 1974.
Vermeulen A., Rubens R., Verdonck L. Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab. 34: 730, 1972.
Vermeulen A., Stoika T., Verdonck L. The apparent free testosterone concentration, an index of androgenicity. J. Clin. Endocrinol. Metab. 33: 759, 1971.
Vermeulen A., Verdonck L. Some studies on the biological significance of free testosterone. J. Steroid Biochem. 3: 421, 1972.
Vermeulen A., Verdonck L. Radioimmunoassay of 17-β-hydroxy-5-androstan-3-one, 4-androstene-3-17-dione, dehydroepiandroster-one, 17-hydroxy-progesterone and progesterone and its application to human plasma. J. Steroid Biochem. 7: 1, 1976.
Vermeulen A., Andò S. Prolactin and adrenal androgen secretion. Glin. Endocrinol. (Oxf.) 8: 295, 1978.
Sonka J., Gregonova I., Pav J., Skiha F. Dehydroepiandrosterone in obese diabetics. Lancet 2: 44, 1964.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andò, S., Rubens, R. & Rottiers, R. Androgen plasma levels in male diabetics. J Endocrinol Invest 7, 21–24 (1984). https://doi.org/10.1007/BF03348370
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348370